Analyst Undervalued Stocks on the ASE December 2024

December 16, 2024

Analyst Undervalued

Companies on this list are considered undervalued based on the analyst consensus. This means that the average analyst target price is greater than the close price.

American Stock Exchange

NYSE American, formerly known as the American Stock Exchange (ASE), and more recently as NYSE MKT, is an American stock exchange located in New York City.

About the Data

This table includes the close price and analyst target price mean from most recent available data. The fiscal year indicates the year for the analyst target price, as the target may not always be for the current year. The number of estimates indicates the number of analyst targets used to calculate the target price mean.

How do you use this table?

Analysts believe that the companies on this list will see the close price move up to their target price mean by the target year indicated. Companies with a large analyst following or large difference between close price and target price are particularly interesting to investigate further. This becomes a starting point for further analysis to understand why these companies are undervalued. Stocks in this category are generally held for capital appreciation or dividends.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose PriceTarget Price MeanTarget YearNumber of EstimatesCurrency
EQX Equinox Gold Corp 5.53 11.09 2025 8 CAD
MAG MAG Silver Corp 14.94 26.78 2025 8 CAD
UUUU Energy Fuels Inc 5.97 12.00 2025 1 CAD
IE Ivanhoe Electric Inc 7.70 22.69 2025 2 CAD
REPX Riley Exploration Permian Inc 32.98 49.50 2025 1 USD
ARMN Aris Mining Corp 3.79 10.40 2025 5 CAD
SLSR Solaris Resources Inc 3.12 11.50 2025 5 CAD
CNL Collective Mining Ltd 3.79 10.75 2025 4 CAD
MTA Metalla Royalty & Streaming Ltd 2.74 7.66 2025 5 CAD
CATX Perspective Therapeutics Inc 3.48 17.33 2025 3 USD
All data provided as at market close December 12, 2024.

Company Details

Equinox Gold Corp

EQX:ASE

Close Price

5.53

Target Price Mean

11.09

Target Year

2025

Target Price # Estimates

8

Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing pipeline of growth projects.

Access the stockcalc valuation


MAG Silver Corp

MAG:ASE

Close Price

14.94

Target Price Mean

26.78

Target Year

2025

Target Price # Estimates

8

MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which achieved commercial production of around 4,000 tonnes per day. The company has also Interest in the Larder project.

Access the stockcalc valuation


Energy Fuels Inc

UUUU:ASE

Close Price

5.97

Target Price Mean

12.00

Target Year

2025

Target Price # Estimates

1

Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming.

Access the stockcalc valuation


Ivanhoe Electric Inc

IE:ASE

Close Price

7.70

Target Price Mean

22.69

Target Year

2025

Target Price # Estimates

2

Ivanhoe Electric Inc is a United States-based minerals exploration and development company with a focus on developing mines from mineral deposits located in the United States.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Riley Exploration Permian Inc

REPX:ASE

Close Price

32.98

Target Price Mean

49.50

Target Year

2025

Target Price # Estimates

1

Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties, and Tennessee Properties, among others.

Access the stockcalc valuation


Aris Mining Corp

ARMN:ASE

Close Price

3.79

Target Price Mean

10.40

Target Year

2025

Target Price # Estimates

5

Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.

Access the stockcalc valuation


Solaris Resources Inc

SLSR:ASE

Close Price

3.12

Target Price Mean

11.50

Target Year

2025

Target Price # Estimates

5

Solaris Resources Inc is advancing a portfolio of copper and gold assets in the Americas, which includes a high-grade resource with expansion and additional discovery potential at the Warintza copper and gold project in Ecuador; discovery potential on the grass-roots Tamarugo project in Chile and Capricho and Paco Orco projects in Peru, and the La Verde joint venture project.

Access the stockcalc valuation


Collective Mining Ltd

CNL:ASE

Close Price

3.79

Target Price Mean

10.75

Target Year

2025

Target Price # Estimates

4

Collective Mining Ltd is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. The company currently has 100% interest in two projects located in Colombia, namely, Guayabales and San Antonio. The company is responsible for discovering, permitting, and constructing the gold mine in Colombia.

Access the stockcalc valuation


Metalla Royalty & Streaming Ltd

MTA:ASE

Close Price

2.74

Target Price Mean

7.66

Target Year

2025

Target Price # Estimates

5

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Access the stockcalc valuation


Perspective Therapeutics Inc

CATX:ASE

Close Price

3.48

Target Price Mean

17.33

Target Year

2025

Target Price # Estimates

3

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Equinox Gold and MAG Silver are among the most undervalued ASE stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-ase-december-2024
Equinox Gold $EQX and MAG Silver $MAG on the #ASE among the most undervalued this month. See the full list of undervalued companies: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-ase-december-2024
Equinox Gold and MAG Silver are among the most undervalued ASE stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-ase-december-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.